From fetal life through adolescence, dramatic changes in pharmacokinetics and pharmacodynamics occur as a consequence of organ maturation and changes in body composition associated with normal development. Accordingly, effective and safe drug therapy in preterm infants, neonates, infants,children and adolescents requires a thorough understanding of human developmental biology and the ontogeny of the processes that govern absorption, distribution, metabolism, excretion, and action of drugs. Physicians must be aware of these interindividual differences, when prescribing drugs. The research presented by this thesis provides an example of an integrated approach to critically examine the pharmacokinetics and pharmacodynamics of midazolam, a benzodiazepine that is finding expanded use in neonatal intensive care units.

, , , ,
J.N. van den Anker (John)
Erasmus University Rotterdam
hdl.handle.net/1765/1173
Erasmus MC: University Medical Center Rotterdam

de Wildt, S. (2001, September 26). Developmental aspects of midazolam metabolism. Retrieved from http://hdl.handle.net/1765/1173


Additional Files
02.pdf Final Version , 221kb
11.pdf Final Version , 182kb
08.pdf Final Version , 182kb
03.pdf Final Version , 178kb
10.pdf Final Version , 169kb
04.pdf Final Version , 148kb
09.pdf Final Version , 117kb
05.pdf Final Version , 114kb
06.pdf Final Version , 107kb
07.pdf Final Version , 95kb
20.pdf Final Version , 69kb
21.pdf Final Version , 69kb
01.pdf Final Version , 54kb
00.pdf Final Version , 50kb
31.pdf Final Version , 45kb
001.pdf Final Version , 32kb
30.pdf Final Version , 30kb
003.pdf Final Version , 21kb